Bio-Rad Laboratories, Inc. Buyback
OLI recorded this information on 11/28/2017
Company:
Bio-Rad Laboratories, Inc.
Buyback:
BIO buyback
$Amount Authorized:
$250,000,000
Buyback Details:
Bio-Rad Laboratories, Inc. (NYSE:BIOandBIOb), a global provider of life science research and clinical diagnostic products, today announced that its board of directors has authorized a new share repurchase program, granting the Company authority to repurchase, on a discretionary basis, up to $250 million of the outstanding shares of the Company's common stock.
Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Co. operates in two segments: Life Science, which develops, manufactures and markets a portfolio of various products; and Clinical Diagnostics, which designs, manufactures, markets and supports test systems, informatics systems, test kits and quality controls that serve clinical laboratories in the diagnostics market.
BIO SEC Filing Email Alerts Service
Open the BIO Page at The Online Investor »
|
||||||||||||||||||||||||
Open the BIO Page at The Online Investor (in a new window) »
 Free BIO Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.25 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: BIO Stock Forecast Based on Zacks ABR data; powered by Xignite |
